The decreasing share among patients having favorable localized PCa who still underwent RP is primarily due to a shift away from GGG 1, whereas pathological tumor stage and PSA levels remained stable within years (see Supplementary Figs. 1, 2, 3). The gene discussed is KLK3; the disease is neoplasm.